搜索临床试验以:Radioactive Iodine
总计831个结果
-
Fujun Zhang招聘中肉瘤、软组织 | 近距离放射治疗 | 聚(ADP-核糖)聚合酶抑制剂中国
-
Grupo Espanol de Tumores NeuroendocrinosIpsen; MFAR招聘中
-
Medical University of BialystokMedical Research Agency, Poland尚未招聘
-
The First Affiliated Hospital of Xiamen University招聘中
-
Peking University Third Hospital招聘中
-
Rijnstate HospitalZonMw: The Netherlands Organisation for Health Research and Development; University of Twente; Amsterdam UMC招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)招聘中
-
Peking University Third HospitalShengli Oilfield Central Hospital; First Affiliated Hospital of the Army Medical University完全的
-
Y-mAbs TherapeuticsMemorial Sloan Kettering Cancer Center完全的
-
Centre Antoine Lacassagne完全的
-
Humanitas Mirasole SpAKU Leuven; UMC Utrecht; University of Sheffield; Istituto Superiore di Sanità; University of Ulm; University... 和其他合作者主动,不招人
-
Translational Research Center for Medical Innovation...Kurosawa Hospital完全的
-
Bayer完全的甲状腺肿瘤美国, 日本, 火鸡, 俄罗斯联邦, 印度, 德国, 法国, 墨西哥, 菲律宾, 希腊, 荷兰, 西班牙, 台湾, 巴西, 埃及, 阿根廷, 阿尔及利亚, 黎巴嫩, 沙特阿拉伯
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Novartis主动,不招人
-
Gustave Roussy, Cancer Campus, Grand Paris主动,不招人RAS 或 BRAF 突变的转移性放射性碘难治性甲状腺癌患者法国
-
Universitair Ziekenhuis Brussel主动,不招人
-
National University Hospital, SingaporeSingapore General Hospital未知
-
Nanjing First Hospital, Nanjing Medical University未知
-
AstraZeneca终止
-
Peking University Third Hospital完全的直肠癌,复发 | 近距离放射治疗、放射性同位素
-
National Cancer Institute (NCI)完全的岛状甲状腺癌 | 复发性甲状腺癌 | II 期滤泡性甲状腺癌 | II 期乳头状甲状腺癌 | IV 期滤泡性甲状腺癌 | IV 期乳头状甲状腺癌美国
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Schering-Plough终止